找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Stereotactic Radiosurgery for Prostate Cancer; Michael J. Zelefsky Book 2019 Springer International Publishing AG, part of Springer Nature

[復(fù)制鏈接]
樓主: PED
21#
發(fā)表于 2025-3-25 05:54:36 | 只看該作者
22#
發(fā)表于 2025-3-25 07:48:41 | 只看該作者
Daniel Lam Cham Kee,Jér?me Doyen,Alexander T. Falk,Jean-Michel Hannoun-Leviat African Americans generally and older African Americans in particular face continued subjugation and economic difficulties due to racial group membership (Hughes and Hertel, 1990). Some suggest that the changes brought about over the past 30 years by civil rights have done little to alter the day
23#
發(fā)表于 2025-3-25 12:45:01 | 只看該作者
24#
發(fā)表于 2025-3-25 19:52:15 | 只看該作者
25#
發(fā)表于 2025-3-25 20:19:25 | 只看該作者
26#
發(fā)表于 2025-3-26 00:30:52 | 只看該作者
Optimizing Selection of Patients for Prostate SBRT: Overview of Toxicity and Efficacy in Low, Interbody of evidence supports the efficacy and safety of SBRT not only for low PCa, but also for intermediate risk disease. We also review some of the reports describing higher than anticipated toxicities, and provide likely explanations for these discrepancies. Potential contraindications to SBRT, such
27#
發(fā)表于 2025-3-26 07:34:25 | 只看該作者
28#
發(fā)表于 2025-3-26 12:28:10 | 只看該作者
Overview of Tumor Control Outcomes with Prostate SBRT for Low and Intermediate Risk Prostate Cancermodalities and difference in clinical outcomes has been shown for those receiving prostatectomy or radiotherapy; high-tier intermediate risk patients, on the other hand have better outcome with combination of EBRT and BT. There is emerging, albeit early evidence that hypofractionated radiotherapy re
29#
發(fā)表于 2025-3-26 13:05:30 | 只看該作者
30#
發(fā)表于 2025-3-26 20:00:24 | 只看該作者
Dose Escalation for Prostate Cancer Using Oligofractionated, Stereotactic Ablative Radiotherapy,for decades, the current form is more apt to avoid toxicity by using modern technological advances in imaging, dosimetry and radiation delivery. In addition to a high likelihood of durable biochemical control, this form of treatment is far more convenient for patients, and potentially reduces the ov
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 10:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
清水县| 安龙县| 米易县| 长子县| 龙游县| 东源县| 文安县| 巴南区| 宜君县| 宝山区| 临沧市| 南丹县| 吉水县| 定远县| 黄骅市| 都江堰市| 临朐县| 徐水县| 澄城县| 平潭县| 鄂托克前旗| 金山区| 文安县| 长沙市| 娱乐| 封开县| 陇川县| 辽阳市| 荣昌县| 边坝县| 开鲁县| 札达县| 银川市| 涟水县| 株洲县| 宁明县| 黄龙县| 仲巴县| 湟中县| 西乌珠穆沁旗| 久治县|